How can high-throughput screening deliver drugs to treat atherosclerosis?

Author： Yang Yuan   Wang Li   Si Shuyi   Hong Bin  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.12, 2010-12, pp. : 1175-1188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Throughput Screening of Neuronal Cl- Channels: Why and How?

By  

Current Neuropharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 207-216

Bentham Science Publishers

Access to resources Recommend Favorite

Technological Advances in High-Throughput Screening

By Bailing Liu   Songjun Li   Jie Hu  

American Journal of PharmacoGenomics, Vol. 4, Iss. 4, 2004-01 ,pp. : 263-276

Adis International

Access to resources Recommend Favorite

The Role of Kinetics in High Throughput Screening for Drugs

By  

Frontiers in Drug Design & Discovery, Vol. 1, Iss. 1, 2005-01 ,pp. : 167-195

Bentham Science Publishers

Access to resources Recommend Favorite

Development of drugs for Epstein–Barr virus using high-throughput in silico virtual screening

By Li Ning   Thompson Scott   Jiang Hualiang   Lieberman Paul M   Luo Cheng  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 12, 2010-12 ,pp. : 1189-1203

Informa Healthcare

Access to resources Recommend Favorite

Non-stoichiometric inhibition in biochemical high-throughput screening

By Coan Kristin ED   Ottl Johannes   Klumpp Martin  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 4, 2011-04 ,pp. : 405-417

Informa Healthcare

Access to resources Recommend Favorite